Last deal

$1.1M

Amount

Post-IPO Equity

Stage

10.07.2023

Date

8

all rounds

$524.7M

Total amount

General

About Company
TherapeuticsMD is a pharmaceutical company that develops safe and effective solutions for women with chronic conditions.

Industry

Sector :

Subsector :

Also Known As

TXMD, AMHN

founded date

01.01.2008

Number of employees

Company Type

For Profit

Last funding type

Post-IPO Equity

IPO status

Private

Description

The company specializes in creating prescription and over-the-counter products exclusively for women, with a focus on hormone replacement therapy for menopause-related symptoms and health risks. Their advanced hormone replacement products have been accepted by the FDA for investigation and aim to alleviate hot flashes, osteoporosis, and discomfort. TherapeuticsMD relies on third-party manufacturers for the production of its drug candidates.
Contacts